Option Care Health, Inc. OPCH

FY2025 · ended Dec 31, 2025 · Revenue $5.65B, +13.0% YoY · Filed Feb 24, 2026

Option Care Health, Inc. (OPCH) files with the SEC under industry code 8082, Services-Home Health Care Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.6 billion and net income of $207.6 million. Free cash flow was $217.1 million. As of Sep 30, 2026 it held $299.1 million in cash and investments and $1.3 billion in total debt.

Revenue (TTM)
$5.75B
+4.0% vs year-ago TTM
Net income (TTM)
$215.19M
+2.9% vs year-ago TTM
Operating cash flow (TTM)
$322.10M
+24.5% vs year-ago TTM
Free cash flow (TTM)
$281.65M
+27.6% vs year-ago TTM
EPS (TTM)
$1.38
+9.8% vs year-ago TTM
Dividend per share
None
Shares outstanding
156.45M
-5.4% vs prior year
Net cash
$-963.45M
as of Sep 30, 2026
Operating margin
5.9%
FY 2026

Company profile

Industry
Services-Home Health Care Services (SIC 8082)
Listed as
OPCH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bannockburn, IL
SEC filer status
Large accelerated filer
SEC CIK
1014739
Former names
BioScrip, Inc. (until Aug 2, 2019); MIM CORP (until Mar 14, 2005)

Other Services-Home Health Care Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$5.6B
$5.0B
$4.3B
$3.9B
$3.4B
Operating income
$337.9M
$321.8M
$314.6M
$240.2M
$190.8M
Net income
$207.6M
$211.8M
$267.1M
$150.6M
$139.9M
Diluted EPS
$1.27
$1.23
$1.48
$0.83
$0.77
Operating cash flow
$258.4M
$323.4M
$371.3M
$267.5M
$208.6M
Free cash flow
$217.1M
$287.8M
$329.4M
$232.2M
$182.9M
Total assets
$3.5B
$3.4B
$3.2B
$3.1B
$2.8B
Total liabilities
$2.1B
$2.0B
$1.8B
$1.7B
$1.6B
Stockholders' equity
$1.3B
$1.4B
$1.4B
$1.4B
$1.2B
Cash and investments
$232.6M
$412.6M
$343.8M
$294.2M
$119.4M
Total debt
$1.3B
$1.2B
$1.2B
$1.2B
$1.2B

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Oct 6, 2026 Oct 5, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Shareholder vote results
May 22, 2026 May 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.